PK/PD and Other Jobs

The URL for this page is

Add your own entry?

Contact email address: - 7th Nov 201 [2971]

Sr. Scientist PBPK and clinical pharmacology--NJ please email me with interest and questions at The Senior Scientist will collaborate with team members to identify and define mechanisms of action, biomarkers and new drug targets. They will help design clinical pharmacology trials and selecting pharmacokinetic (PK)/pharmacodynamic (PD) /biomarker assessments throughout development, develop physiologically-based pharmacokinetic (PB-PK) models, evaluate new formulations effect on PK. Will conduct PK/PD analysis and reporting, contribute relevant sections to regulatory filings, work with pharmacometricians to develop PK/PD models and contribute to commercial strategies.

Key responsibilities

Contact email address: - 4th Nov 201 [2970]

Basilea Pharmaceutica Ltd. is a commercial stage biopharmaceutical company, headquartered in the heart of the life sciences hub of Basel, Switzerland. We are an innovative and multinational team of 225 employees worldwide and committed to discovering, developing and bringing to market medicines that make a clear difference to the lives of patients. Our activities are focused on the therapeutic areas of oncology and anti-infectives, with two commercialized drugs in our portfolio (Cresemba(R) and Zevtera(R)).

For our headquarter in Basel we are currently looking for a Senior Clinical Pharmacologist (M/F) to join our team

Your tasks

Your profile Basilea is committed to putting people first. In addition to competitive remuneration, we offer the opportunity to work on interesting, cross-functional projects in an engaging working environment. We strongly believe that every employee can make an impact and is vital to our success.
If you wish to become part of a company that strives to make a difference to the lives of patients worldwide, we are looking forward to receiving your application via our careers portal.

External website

Contact email address: - 16th Oct 201 [2968]

PhD Studentship at University of Manchester (MRC DTP): Model-driven optimization of drug therapy and individualisation of healthcare in chronic kidney disease

Funding: MRC DTP studentship funding for tuition fees and stipend for 3.5 years

Supervisors: Dr Aleksandra Galetin (PI), Dr Daniel Scotcher

Background: Chronic kidney disease (CKD) is associated with increasing age, as approximately 50% of individuals over 75 years are affected by some degree of kidney disease. The ageing population is also more likely to have common comorbidities (cardiovascular diseases, diabetes) and be prescribed multiple medications, and hence the risk of potential drug-drug interactions (DDI) in patients with renal impairment is high. However, high percentage of drug product labels lack any evidence-based recommendations for dosage adjustment in patients with advanced renal impairment. Therefore, CKD patients are susceptible to adverse side effects of drugs (e.g., drug induced kidney injury) and increased risk of inappropriate dosing. Model-based precision dosing is an approach for determining suitable dose adjustments using in silico tools (e.g., physiologically-based pharmacokinetic (PBPK) models) to improve drug efficacy and safety in specific populations such as CKD.

Project Aims: This project aims to develop quantitative translational tools to facilitate individualized healthcare in CKD and provide guidance to clinicians for rational dose adjustment when direct evidence in this patient population is lacking. CKD patients exhibit impaired active tubular secretion and therefore reduced renal excretion mediated via renal transporters. PBPK modelling in this project will implement different disease-related perturbations of active secretion and focus on selected renal transporter probes with reported nephrotoxicity/clinical data in patients with advanced CKD. The modelling and simulation will be supported by in vitro studies where activity of selected renal transporters (e.g., OAT1) will be investigated under different experimental conditions mimicking CKD. Uptake of selected drugs (same as used for modelling purposes) in proximal tubule cells will be investigated with cells exposed to plasma from healthy and subjects with severe CKD (to be obtained from collaborator Prof. Philip Kalra, Salford Royal Hospital, Manchester). Functional transporter studies will be supported by LC-MS proteomic measurements of the transporter expression in different experimental conditions and related to protein expression in vivo.

Training The successful applicant will receive state-of-the-art training to build a broad and transferable skillset including in vitro cellular assays, proteomics analysis and PBPK modelling. Active participation in the Centre for Applied Pharmacokinetic Research (CAPKR), University of Manchester will provide opportunity to interact with a multi-disciplinary research team. Student will be encouraged to attend international conferences to promote work and build network as an independent researcher, as well as publish in highly-cited peer reviewed journals. The proposed inter-disciplinary and model-driven approach has strong foundations and builds upon previous and ongoing research in CAPKR.

Eligibility: UK/EU nationals only

Applications: Enquiries about the project should be sent to Dr Aleksandra Galetin:

Applications should be made via the University of Manchester website:

External website

13th Sep 201 [2967]

Scientific Director Discovery NCE DMPK (all genders)

Your role:

We are seeking an experienced Scientific Director to join our Discovery DMPK team Darmstadt Germany.

As Scientific Director you will champion and develop new scientific ideas and concepts specifically focused on DMPK-related activities. This will include scientific excellence and validation of in vitro, in vivo and in silico DMPK assays. You will provide support for external opportunity evaluations. The role coaches peers and contribute to maintaining a strategic network within and outside. You will provide scientific input to DMPK strategic goals and contribute to the overall goal of Discovery DMPK of selecting high quality molecules to advance in our pipeline. The Scientific Director will collaborate with the Development DMPK teams to ensure that the right development studies are conducted to manage risk and de-risk identified liabilities. The role will have good understanding of PK/PD models preferentially with hands-on experience in using them to support discovery projects.

You will be DMPK representative in project teams and support projects from concept generation up to selection of development candidates (and beyond when needed). As project representative, you will identify DMPK related key issues in Discovery projects and provide inputs to the design of new molecules to address these issues. The Scientific director will compile DMPK data to predict human PK, and in collaboration with other relevant disciplines (Clinical Pharmacology, Discovery Pharmacology, Safety, Formulation, etc) predict human efficacious dose.

Who you are:

External website

26th Aug 201 [2963]

Summary The Director of the Preclinical Pharmacokinetics and Pharmacodynamics group will be responsible for leading a group of scientists responsible for the design, pharmacokinetic analysis, and reporting of non-clinical animal pharmacokinetic, toxicokinetic, and ADME studies. The Director will be responsible for the oversight of external pharmacokinetic studies, establish deliverables, maintain timelines, and foster open communication with and between the Project Teams, Preclinical Operations, members of the Preclinical PK/PD group, Pharmacometrics, Toxicology and Functional Heads. Responsibilities will also include reviewing and providing content and subject matter expertise relating to preclinical pharmacokinetics, toxicokinetics and ADME sections of regulatory documents to include: INDs, BLAs and other regulatory submissions and responses, as needed.



External website

Contact email address: - 22nd Aug 201 [2961]

About Idorsia Pharmaceuticals Ltd

Idorsia Ltd is reaching out for more - We have more ideas, we see more opportunities and we want to help more patients.

In order to achieve this, we will develop Idorsia into one of Europe’s leading biopharmaceutical company, with a strong scientific core.

Headquartered in Switzerland - a European biotech hub - Idorsia is specialized in the discovery and development of small molecules, to transform the horizon of therapeutic options. Idorsia has a broad portfolio of innovative drugs in the pipeline, an experienced team, a fully-functional research center, and a strong balance sheet – the ideal constellation to bringing R&D efforts to business success.

Idorsia was listed on the SIX Swiss Exchange (ticker symbol: IDIA) in June 2017 and has over 600 highly qualified specialists dedicated to realizing our ambitious targets. ob Responsibilities

Providing quantitative pharmacokinetic and pharmacodynamic modeling and simulation expertise to pre-clinical project and Life cycle teams Applying quantitative PK/PD modeling and simulation to inform pre-clinical candidate selection Being a champion and advocate for pharmacometrics within the company Analyzing, interpreting and reporting pharmacokinetic and pharmacodynamic data from pre-clinical studies Performing PK/PD simulations and predicting pre-clinical and clinical PK from nonclinical data as appropriate Collaborating, mentoring and guiding other DMPK team members with pharmacometric support on their projects Interacting cross-functionally with other departments including Medical Organization, Toxicology, Formulation and Discovery Preparing and/or reviewing PK, PK/PD components of internal documents, briefing books and regulatory submission documents (e.g. IND, NDA, IB) Actively preparing, reviewing and publishing scientific papers and abstracts Representing the DMPK line on project teams spanning Discovery to NDA

Candidate’s Requirements

What Idorsia offers Work Location: Allschwil
Country: Switzerland
Business Area: Drug Discovery - Pharmacology DMPK
Schedule: Fulltime
Job Type: Permanent
Job ID: 1256 Please apply exclusively via the career portal on our home page.

External website

Contact email address: - 2nd Aug 201 [2960]

URGENT CLIN PHARM M/S QSP NEED: Director level roles. Individual contributor or roles that require the management, training and mentoring of junior scientists. Progress your career in a growing environment that is on the cutting edge. Openings in small molecule, gene therapy and antibodies

Director, Clinical Pharmacology

Job Description

Company is looking for a Clinical Pharmacology leader to join the team in Boston, MA. The Clinical Pharmacology leader is a highly scientific role, supporting multiple facets of Clinical Pharmacology, including study design, PK and PK/PD analyses, and overall drug development support. He/She will complete assigned work in a resourceful, self-sufficient manner and will be able to create alternative approaches to achieve desired results if needed. The candidate will have an excellent knowledge of Clinical Pharmacology principles, such as PK, PK/PD, drug metabolism, and DDI, as well as a good understanding of related disciplines such as pharmaceutical development, regulatory, and overall drug development.

Key Responsibilities:

Minimum Qualifications

External website

2nd Aug 201 [2959]

Pharmacometrician - Brisbane, Australia

The Position

Model Answers R&D Pty Ltd is seeking applications for a pharmacometrician to join their team in Brisbane, Australia. The successful applicant will work in an inspiring group that provides a range of quantitative solutions to a global client network. The position would suite a highly motivated individual with a desire to continuously learn, and looking for a challenging opportunity to facilitate successful drug development. Applicants should have excellent time management and communication skills with a background in pharmacokinetic / pharmacodynamic data analysis. Applicants should also have programming experience in SAS, R or SPlus, and demonstrated modelling experience using NONMEM or equivalent software.

Essential Skills:

We will train, support and assist you in: The Location and Company

All positions are located in the central business district of Brisbane. Model Answers R and D Pty Ltd is a growing consultancy business dedicated to helping pharmaceutical and biotech companies make successful drug development decisions. Employees, shareholders and equity stake holders are expected to be upstanding members of the community, who have an inbuilt desire to develop, create, and innovate. Opinions and ideas are welcomed, resulting in a dynamic business, led by those who work in the business.

Interested applicants should apply via or refer to our website ( for further information. Applications close 26 August 2019.

External website

Contact email address: - 18th Jul 201 [2950]

Rosa and Co. LLC is expanding and seeking a Biological Systems Modeler, an Associate Life Scientist, as well as a Senior Life Scientist, to join our PhysioPD consulting practice.

Rosa is a drug-disease modeling and simulation company created to provide innovative modeling solutions to its biopharmaceutical clients and meaningful equity ownership to its employees.

Life Scientists and Modeling Engineers work together in our PhysioPD practice to develop physiologically-based, dynamic mathematical models and conduct simulations of disease, drug action, and (pre)clinical studies.

Full and part-time employment and project-based contracting opportunities are available throughout the United States.

Rosa is an equal opportunity employer. Upon hiring, proof of eligibility to work in the United States will be required.

For more information, visit

External website

Contact email address: - 17th Jul 201 [2949]

Senior Scientist or Associate Director Clinical Pharmacology

Key Responsibilities

Independently represent DMPK, Clinical Pharmacology as a core member of clinical trial working groups (CTWG): Contributing to clinical trial designs Authoring clinical study protocols Executing and coordinating clinical trial conduct Finalizing clinical study reports All of this to be performed within agreed timelines and meeting all regulatory requirements.

Align plans with sub-teams, study teams, manager and DMPK senior staff. Manage CROs for clinical pharmacology related studies and activities: Developing study timelines, objectives and budgets Ensuring accuracy of project progress and completion Pro-actively identifying hurdles and providing solutions. Analyze and interpret PK/PD data generated during conduct of the clinical trials Communicating results and impact of results in a timely and effective manner to clinical study teams and development sub-teams.

Participate in and eventually lead internal DMPK sub-teams to define DMPK strategy for compound development. Actively participate in cross-departmental teams, department-wide initiatives and work streams. Present and publish internally and externally as main contributor to enhance visibility of DMPK, Clinical Pharmacology department. Complete all required organizational trainings and requirements according to corporate timelines and adhere to the appropriate SOP and GxP guidelines.

Minimum Requirements

Education: PhD or PhD accompanied with post-doctoral training in clinical pharmacology, pharmaceutical sciences or related areas such as pharmacokinetics, pharmacology or drug metabolism. Experience in conducting clinical pharmacology studies including study design, PKPD data analysis and/or population PK analysis, and result interpretation is required. A working knowledge and previous experience, either in the industry or as part of the educational training, with pharmacokinetic/pharmacodynamics, drug metabolism, drug-drug interactions, and population PKPD modeling is required. Must excel at working in a highly collaborative matrix team environment, have good organizational, communication [both oral and written], and interpersonal skills. Must be able to work independently. Preferred Qualifications

2-6 years of industry experience working as a clinical pharmacologist. Level is flexible, exact level and responsibilities will depend on the individual’s experience and interpersonal skills.

Working experience with DMPK- bioanalysis, data management and statistical programming groups is preferred. Prior experience working with CROs is preferred. Broad familiarity with the drug development process, preferably in oncology and rare disease areas is highly desired. Preferably 3 years of relevant experience in drug development. Advanced training in WinNonlin, R, SAS, NONMEM and/or Monolix would be a plus.

External website

Contact email address: - 17th Jul 201 [2948]

In this newly created role, you will have the opportunity to independently lead the clinical pharmacology strategy for DCC–3014, a clinical stage selective inhibitor of CSF1R, and play a key role in the upcoming regulatory meetings.

In this highly visible role, you will present clinical pharmacology plans, updates, and results to project teams and senior management. This is an exciting opportunity to provide leadership to the clinical pharmacology function, provide support to the Director and mentor junior team members.

This position will report to the Director of Clinical Pharmacology.

Key Responsibilities:


External website

Contact email address: - 1st Jul 201 [2947]

Biotech Translational Scientist

DC Area
My client is expanding and looking to hire a Scientist for their development group. This is a high impact role - the ideal candidate will take on the following tasks:

The ideal candidate will possess the following qualities: Competitive salary + bonus + relocation and more!

Please contact Kerry Boehner at KOB Solutions at if you have any questions or would like to pursue.
thank you!

External website

21st Jun 201 [2946]

PK/PD Postdoctoral Research Associate

Location: University of North Carolina at Chapel Hill, Eshelman School of Pharmacy

Job Description: A Postdoctoral Research Associate position is available immediately to work on projects focused on characterizing the pharmacokinetic/pharmacodynamic properties of Direct Oral Anticoagulants (DOACs). Eventually, work on other therapeutic areas will also be involved. The projects will involve use of nonlinear mixed effects and physiologically based pharmacokinetic modeling techniques to identify patients that require dose adjustment and individualization.

Educational Requirements: PharmD, MD, or PhD.

Qualifications and Experience

Equal Opportunity Employer

The University of North Carolina at Chapel Hill is an equal opportunity and affirmative action employer. All qualified applicants will receive consideration for employment without regard to age, color, disability, gender, gender expression, gender identity, genetic information, race, national origin, religion, sex, sexual orientation, or status as a protected veteran.

Required Documents

Curriculum Vitae /Cover letter /List of References

External website

Contact email address: - 19th Jun 201 [2945]

A two-year postdoctoral fellowship in the Disease and Therapeutic Response Modeling and A two-year post-doctoral fellowship is available within the Disease and Therapeutic Response Modeling and Simulation Program, Division of Clinical Pharmacology, Department of Medicine at the Indiana University School of Medicine. The postdoctoral fellow will join our individualized training program in quantitative clinical pharmacology and pharmacometrics, including application of non-linear mixed effects modeling, physiological-based pharmacokinetic modeling, data mining, machine learning, and quantitative systems pharmacology. Trainees will benefit from interactions with the Division’s T32 Clinical Pharmacology Fellowship program, experts in clinical pharmacology, biostatistics, computational biology, and bioinformatics, as well as faculty with long-term experience in the pharmaceutical industry. Candidates will develop the critical skills necessary for participation in state-of-the-art pharmaceutical research, including support of the Preclinical Trial Core of the MODEL-AD Alzheimer’s disease research program. Additionally, the candidate will have the opportunity to support projects in other therapeutic areas of interest, including women’s health, oncology, pediatrics, nephrology, psychiatry, and mechanistic modeling of drug-drug interactions. Candidates are also encouraged to pursue methodological topics relevant to clinical interests of the Program.

Basic Qualifications
Our interdisciplinary team is looking for a motivated, ambitious and creative individual with excellent written and verbal communication skills.
PharmD, MD, or PhD in pharmacology, systems biology/pharmacology, pharmacometrics, bioengineering, biostatistics, computational biology, or related fields.
Preference will be given to candidates with strong quantitative skills and computational experience (R, Matlab, Python, Nonmem, etc); however, candidates with a strong desire to integrate such analyses with pre-clinical and/or clinical drug studies are also encouraged to apply.

External website

17th Jun 201 [2944]

Your Role:

The Head of Global DMPK:

Provides strategic impact through: Who You Are: Hear more about the role here:

Apply Here:

External website

Contact email address: - 7th Jun 201 [2943]

Director Pharmacometrics

Well established company looking for director and future head of the clinical pharmacology and pharmacometrics department. This role will be an individual contributor primarily in M&S but will have the opportunity to mentor and train junior scientists.

This company is working with small molecules, large molecules, SiRNA, and monoclonal antibodies.

Let me know if you'd like to learn more.

External website

Contact email address: - 3rd Jun 201 [2942]

Senior Pharmacokinetics / Pharmacokinetic Scientist - Anywhere, US Office-based or Remote-based

Who We Are
Synteract is a global full-service contract research organization with a successful three-decade track record supporting biotechnology, medical device and pharmaceutical companies. With our mission of ”Bringing Clinical Trials to Life,” we provide customized Phase I through IV services internationally, offering expertise across multiple therapeutic areas including notable depth in Oncology, Neuro Degenerative Diseases, and Rare and Orphan Diseases, and in pediatric populations. Our mission is to support the innovation and development of better therapies in healthcare.

Position Overview
The Senior Pharmacokinetics / Pharmacokinetic Scientist conducts PK/PD modeling and population PK analyses using WinNonLin, NonMem and PKSim with a focus on designing optimal dosing regimens for pediatric patients and other special patient populations. Provide pharmacology, pharmacokinetic consulting to clients with a specialization on pediatric patient populations. Design, analyze and report pre-clinical and clinical pharmacokinetic, PK/PD modeling and trial simulation studies. Be the subject-matter expert on pediatric dosing methodologies including allometric scaling approaches.

Specific tasks would include:
Conduct PK/PD analyses, modeling and simulation in WinNonLin, NonMem and PK-Sim for pediatric patients other special patient populations requiring dose regimen modification. Assist clients in the design and development of pre-clinical and clinical protocols with respect to toxicokinetic and pharmacokinetic analyses When the lead PK Scientist on assigned projects, act as the project manager to include functioning as the principal liaison with key clients, vendors, and internal team members. When the lead PK Scientist, will create trust and confidence amongst clients, vendors and team members while delivering on-time, and on-budget programs that leverage the various resources, expertise and cross function knowledge available within Synteract. Work with client’s data management group to prepare datasets for import and analysis in WinNonLin. Conduct non-compartmental (NCA) and compartmental PK analysis is Phoenix WinNonLin-PKSo. Responsible for locking and unlocking studies/scenarios in the PKSo database following management authorization. Writing stand-alone PK reports and PK study report sections for CSR’s Responsible for ensuring study data and study reports are retained according to the corporate records retention policy. Ensuring corporate quality policies and SOPs are followed during the analysis and reporting of PK studies Provide pharmacology, pharmacokinetic and drug development consulting services to clients with a specialization in pediatric drug development.

Ph.D. in Pharmacokinetics or Pharmaceutical Sciences, plus knowledge of how to support pediatric Pharmacokinetic/Pharmacodynamic modeling and simulations, specifically population PK. Pediatric knowledge can be gained concurrently through Ph.D. program, as a postdoctoral fellow, or in a professional position. 10% domestic travel to meetings/conferences/client sites If you’re passionate about bringing clinical trials to life, we encourage you to apply today!

Synteract’s policy is to provide equal employment opportunity and affirmative action in all of its employment practices without regard to race, color, religion, sex, national origin, ancestry, marital status, protected veteran status, age, individuals with disabilities, sexual orientation or gender identity or expression or any other legally protected category. Applicants for positions with Synteract must be legally authorized to work in the country which they are applying and verification of employment eligibility will be required as a condition of hire. The Company will not sponsor applicants [to this position] for work visas.

External website

Contact email address: - 28th May 201 [2941]


The University of Kentucky Department of Pharmaceutical Sciences is recruiting a postdoctoral scholar in pharmacokinetics/pharmacology. The postdoc will participate in an exciting drug development project to further the development of lead drug candidates for the treatment of Ewing Sarcoma. The project involves both research efforts and pre-IND activities. The position seeks a trainee whose primary expertise are in Pharmacokinetics and Drug Metabolism but is willing to extend her/his skillset and incorporate other pharmacology studies such as tumor xenografts for efficacy assessment. Expertise in bioanalytical methods are also desirable but not critical. The post-doc will perform sample preparation, LC-MS instrument maintenance and operation to acquire highly reproducible data and metabolite identification. They will contribute to study design and/or conduct of animal experiments and will perform PK/PD modeling and statistical analysis. The post-doc is expected to work independently but will interface with the PI, senior graduate students, staff, and collaborators.

External website

Contact email address: - 27th May 201 [2940]

Job Description: Two postdoc opportunities in PBPK Modeling, Risk Assessment, and Computational Toxicology are available at Kansas State University. The incumbent of the first position will work with Dr. Zhoumeng Lin on PBPK modeling projects at K-State in the first year, and then will move to University of California at Davis to receive additional training in experimental animal techniques and analytical chemistry methods under the mentorship of Dr. Lisa Tell in the second year. The second position will work with Dr. Zhoumeng Lin at K-State on projects related to PBPK modeling, risk assessment and computational toxicology. A PhD in pharmacometrics, pharmacology, toxicology, epidemiology, environmental health, engineering, biostatistics, bioinformatics, or a related field is required.

How to Apply: Please refer to the following webpages for detailed job description and application instructions. Position 1: Position 2: Screening of applicants begins on June 28, 2019 and will continue until the position is filled.

Questions: Please send your inquiry with a copy of updated CV to Dr. Zhoumeng Lin at For more information about Dr. Lin’s research and teaching, please visit his laboratory website (

Kansas State University is an equal opportunity employer and actively seeks diversity among its employees. Background check is required.

External website https://

Contact email address: - 15th May 201 [2939]

Sr. Scientist or Principal Scientist

My client is looking for a clin pharm scientist to work on anti-body programs for oncology. Responsibilities:


External website

Contact email address: - 7th May 201 [2938]

Head of DMPK

Small company is looking for a Head of DMPK that is well versed in early stage oncology programs. The incumbent will work primarily with CRO's and provide strategic oversight for all things ADME & DMPK. Incumbent will have full oversight of outsourced PK/PD modeling and simulations.

Small molecule experience is essential and antibody experience is an added bonus. Extensive knowledge of regulatory requirements and GLP, GCP and ICH experience is necessary to be successful in this role.

Please let me know if you'd like to learn more about this exciting opportunity.

External website

Last update: Thu 7 Nov 2019 04:47:55 pm

Copyright © 2003-2019 David Bourne (